Rapidly Rising RMAT Designations Crack CBER’s Communication Freeze

The US FDA is receiving more requests for regenerative medicine advanced therapy designation and granting more of them, according to recently reported agency data.

The FDA's regenerative medicine advanced therapy (RMAT) designation helps cultivate the next crop of biologic therapies. (Shutterstock)

More from Cell & Gene Therapies

More from Regulatory Trackers